SGTX Sigilon Therapeutics Inc.
32.79
-0.59 -2%
Previous Close
33.38
Open
33.79
52 Week Low
22
52 Week High
54.3167
Market Cap
$1,024,312,254
Shares
31,240,271
Float
16,381,016
Enterprise Value
$1,055,242,847
Volume
48,031
Av. Daily Volume
142,544
Drug Pipeline
| Drug | Stage | Notes |
|---|---|---|
|
SIG-001
Hemophilia A
|
Phase 1/2
Phase 1/2
|
Phase 1/2 initiation of dosing October 2020.
|